<p>(A, B) Migration assay: A2780/eIF6 and control cells were treated with DAPT 75 µM or DMSO for 36 h then seeded in the upper side of migration chambers. The cells migrated to the lower chambers after 36 h of incubation were stained with crystal violet dye. (C, D) Invasivity assay: cells were treated with DMSO or DAPT 75 µM for 36 hours and seeded in the upper side of invasion chambers. After 36 h, cells migrated in the lower chamber were stained. The total stained area in the lower chambers was estimated using the Image-J software. The histograms in (B) and (D) represent the average of three independent experiments. P values estimating the statistical significance of the observed experimental variations between different data sets (contro...
<p>A) HEY cells were transiently transfected with E2F1 or eGFP as a control and treated for 24 hours...
<p><b>A and B.</b> Immortalized human ovarian cancer cells derived from patient ascites (HA1 and HA2...
<p>A) Wound healing assay images at the indicated time points. B) Wound width distance at the indica...
(A) Silencing of Efp decreases migration in Ishikawa cells. Cells transfected with siEfp #A, #B, or ...
<p>(A) The images show the result of a migration assay and were taken after a 24 h/37°C incubation o...
BACKGROUND: Eukaryotic Initiation factor 6 (eIF6) is a peculiar translation initiation factor that ...
<p><b>A</b>. Wound-healing assay was performed to examine the migration rate of SKOV3 cells transduc...
<p>OVCA433 cells with stable expression of GFP/GRB7 (OVCA433-GRB7) were treated with DMSO as control...
<p>A) Cells were treated with G6 for 24 hours at the indicated concentrations, washed, and a scratch...
eIF6 over-expression increases the motility and invasiveness of cancer cell over-expression was gene...
<p>HCC827 GR5-G (maintained in the absence of gefitinib for 10 days) were transfected with EGFR siRN...
BACKGROUND: Eukaryotic Initiation factor 6 (eIF6) is a peculiar translation initiation factor that ...
<p>A, The intrinsic migration and invasion of cells. B and C, Cells were treated with increasing dos...
<p>The treatment with rhSTIP1 promoted cell migration according to the results of both Transwell mig...
<p>(<b>A</b>) Wound healing assays with primary HFKs stably expressing HPV16 E6 (E6) or infected wit...
<p>A) HEY cells were transiently transfected with E2F1 or eGFP as a control and treated for 24 hours...
<p><b>A and B.</b> Immortalized human ovarian cancer cells derived from patient ascites (HA1 and HA2...
<p>A) Wound healing assay images at the indicated time points. B) Wound width distance at the indica...
(A) Silencing of Efp decreases migration in Ishikawa cells. Cells transfected with siEfp #A, #B, or ...
<p>(A) The images show the result of a migration assay and were taken after a 24 h/37°C incubation o...
BACKGROUND: Eukaryotic Initiation factor 6 (eIF6) is a peculiar translation initiation factor that ...
<p><b>A</b>. Wound-healing assay was performed to examine the migration rate of SKOV3 cells transduc...
<p>OVCA433 cells with stable expression of GFP/GRB7 (OVCA433-GRB7) were treated with DMSO as control...
<p>A) Cells were treated with G6 for 24 hours at the indicated concentrations, washed, and a scratch...
eIF6 over-expression increases the motility and invasiveness of cancer cell over-expression was gene...
<p>HCC827 GR5-G (maintained in the absence of gefitinib for 10 days) were transfected with EGFR siRN...
BACKGROUND: Eukaryotic Initiation factor 6 (eIF6) is a peculiar translation initiation factor that ...
<p>A, The intrinsic migration and invasion of cells. B and C, Cells were treated with increasing dos...
<p>The treatment with rhSTIP1 promoted cell migration according to the results of both Transwell mig...
<p>(<b>A</b>) Wound healing assays with primary HFKs stably expressing HPV16 E6 (E6) or infected wit...
<p>A) HEY cells were transiently transfected with E2F1 or eGFP as a control and treated for 24 hours...
<p><b>A and B.</b> Immortalized human ovarian cancer cells derived from patient ascites (HA1 and HA2...
<p>A) Wound healing assay images at the indicated time points. B) Wound width distance at the indica...